SE468035B - Anvaendning av d-sotalol, ett medel ur klass iii foer behandling av arytmi - Google Patents

Anvaendning av d-sotalol, ett medel ur klass iii foer behandling av arytmi

Info

Publication number
SE468035B
SE468035B SE8402756A SE8402756A SE468035B SE 468035 B SE468035 B SE 468035B SE 8402756 A SE8402756 A SE 8402756A SE 8402756 A SE8402756 A SE 8402756A SE 468035 B SE468035 B SE 468035B
Authority
SE
Sweden
Prior art keywords
sotalol
acid
class iii
action potential
treatment
Prior art date
Application number
SE8402756A
Other languages
English (en)
Swedish (sv)
Other versions
SE8402756L (sv
SE8402756D0 (sv
Inventor
A Simon
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23976573&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE468035(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SE8402756D0 publication Critical patent/SE8402756D0/xx
Publication of SE8402756L publication Critical patent/SE8402756L/
Publication of SE468035B publication Critical patent/SE468035B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Light Receiving Elements (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
SE8402756A 1983-05-23 1984-05-22 Anvaendning av d-sotalol, ett medel ur klass iii foer behandling av arytmi SE468035B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49736883A 1983-05-23 1983-05-23

Publications (3)

Publication Number Publication Date
SE8402756D0 SE8402756D0 (sv) 1984-05-22
SE8402756L SE8402756L (sv) 1984-11-24
SE468035B true SE468035B (sv) 1992-10-26

Family

ID=23976573

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8402756A SE468035B (sv) 1983-05-23 1984-05-22 Anvaendning av d-sotalol, ett medel ur klass iii foer behandling av arytmi

Country Status (21)

Country Link
EP (1) EP0127435B1 (de)
JP (1) JPS59222411A (de)
AT (2) AT386121B (de)
BE (1) BE899717A (de)
CA (1) CA1237079A (de)
CH (1) CH662055A5 (de)
CY (1) CY1552A (de)
DE (2) DE3419067A1 (de)
DK (1) DK161363C (de)
FI (1) FI842041A (de)
FR (1) FR2548898B1 (de)
GB (1) GB2141339B (de)
HK (1) HK74891A (de)
IT (1) IT1209547B (de)
LU (1) LU85371A1 (de)
MY (1) MY100562A (de)
NL (1) NL8401644A (de)
NZ (1) NZ208229A (de)
SE (1) SE468035B (de)
SG (1) SG41290G (de)
ZA (1) ZA843871B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0697407B1 (de) 1994-08-19 1997-06-25 MITSUI TOATSU CHEMICALS, Inc. Pyrimidin-Dion-Derivate und diese enthaltende antiarrhythmische Zusammensetzungen
US5874475A (en) * 1995-12-21 1999-02-23 Pharmacia & Upjohn Company Antiarrhythmic (S)-enantiomers of methanesulfonamides
CA2207545C (en) * 1995-01-10 2008-02-26 Pharmacia & Upjohn Company Antiarrhythmic (s)-enantiomers of methanesulfonamides
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US334158A (en) * 1886-01-12 Geoege w
FR148F (de) * 1962-01-24

Also Published As

Publication number Publication date
FR2548898A1 (fr) 1985-01-18
FI842041A0 (fi) 1984-05-22
JPS59222411A (ja) 1984-12-14
IT1209547B (it) 1989-08-30
AT386121B (de) 1988-07-11
ZA843871B (en) 1985-01-30
FI842041A (fi) 1984-11-24
DK161363C (da) 1991-12-09
IT8421046A0 (it) 1984-05-22
CA1237079A (en) 1988-05-24
NZ208229A (en) 1988-02-12
JPH0377172B2 (de) 1991-12-09
GB2141339A (en) 1984-12-19
LU85371A1 (fr) 1985-03-21
EP0127435A3 (en) 1986-07-30
CH662055A5 (de) 1987-09-15
ATE66603T1 (de) 1991-09-15
ATA170584A (de) 1987-12-15
DK251784A (da) 1984-11-24
EP0127435B1 (de) 1991-08-28
DE3419067A1 (de) 1984-11-29
NL8401644A (nl) 1984-12-17
CY1552A (en) 1991-03-22
GB2141339B (en) 1987-08-26
HK74891A (en) 1991-09-27
SE8402756L (sv) 1984-11-24
GB8413217D0 (en) 1984-06-27
DE3419067C2 (de) 1989-09-21
DE3484971D1 (de) 1991-10-02
DK161363B (da) 1991-07-01
SE8402756D0 (sv) 1984-05-22
SG41290G (en) 1990-08-03
FR2548898B1 (fr) 1987-05-15
DK251784D0 (da) 1984-05-22
BE899717A (fr) 1984-11-22
MY100562A (en) 1990-11-15
EP0127435A2 (de) 1984-12-05

Similar Documents

Publication Publication Date Title
US4937267A (en) Method of treatment of obesity
EA013084B1 (ru) Модуляторы метаболизма и лечение связанных с ним нарушений
HUT76852A (en) Use of benzotiophene derivatives for production of pharmaceutical compositions useful for inhibiting conditions associated with neuro-peptide y
AU687746B2 (en) Use of norastemizole for the treatment of allergic disorders
EP2806865A1 (de) Kombinationstherapien mit späten ionenkanalblockern und kaliumionenkanalblockern
WO2008115443A1 (en) Kinase protein binding inhibitors
BR112017012396B1 (pt) Combinação farmacêutica que compreende um agonista seletivo do receptor s1p1
JPH07506828A (ja) 肝臓が損われた患者での抗ヒスタミン剤としてのターフェナジン誘導体の用途
SE468035B (sv) Anvaendning av d-sotalol, ett medel ur klass iii foer behandling av arytmi
JP2003267890A (ja) 不整脈および発作の治療または防止における５−ｈｔ４受容体拮抗剤の使用
US20060106030A1 (en) Structurally rigid dopamine d3 receptor selective ligands and process for making them
US6458809B1 (en) Methods for treating disorders using norastemizole in combination with other active ingredients
Sachar et al. Thioridazine stimulates prolactin secretion in man
HRP20020178A2 (en) Use of bis-sulphonamides for producing medicaments used for preventing or treating hyperlipidaemia
US4404226A (en) Use of guanfacine in treating schizophrenia
US9126989B2 (en) Compound and methods for treating long QT syndrome
WO2017147601A1 (en) Methods of improving balance, gait or both in patients with neurological disease
JPH0840893A (ja) インターロイキン−１産生抑制剤
Kobayashi et al. The Conventional Antihistamine Drug Cyproheptadine Lacks QT-interval–Prolonging Action in Halothane-Anesthetized Guinea Pigs: Comparison With Hydroxyzine
SE502323C2 (sv) Användning av N-(2-hydroxietyl)nikotinamidnitrat eller ett farmaceutiskt godtagbart salt därav för framställning av ett läkemedel aktivt för behandling av sjukdomar förbundna med cerebral ischemi
US3907999A (en) Substituted dibenzocyclooctene compositions
BR112019003189A2 (pt) composto, composição farmacêutica, processo para a produção da composição farmacêutica
EP0621781A1 (de) Verwendung von 3-arylindol- und 3-arylindazolderivaten zur behandlung von psychosen
GB2084570A (en) Benzanilide derivative
AU7252700A (en) Use of norastemizole for the treatment of allergic disorders

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8402756-4

Format of ref document f/p: F

NUG Patent has lapsed